Azenta, Inc. (LON:0HQ1)
London flag London · Delayed Price · Currency is GBP · Price in USD
28.16
-1.00 (-3.43%)
Feb 12, 2026, 4:53 PM GMT

Revenue by Geography

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
United States Revenue
-365.00M365.05M
United States Revenue Growth
--0.01%3.88%
China Revenue
-58.35M58.24M
China Revenue Growth
-0.18%11.72%
United Kingdom Revenue
-35.39M27.20M
United Kingdom Revenue Growth
-30.08%2.04%
Rest of Europe Revenue
-107.37M95.15M
Rest of Europe Revenue Growth
-12.84%9.14%
Asia Pacific/ Other Revenue
-27.71M27.79M
Asia Pacific/ Other Revenue Growth
--0.29%-18.50%
Revenue (Total)
594.95M593.82M573.45M
Revenue (Total) Growth
0.19%3.55%3.98%

Revenue Breakdown

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Sample Management Solutions Revenue
324.38M324.59M318.90M
Sample Management Solutions Revenue Growth
-0.07%1.79%5.18%
Multiomics Revenue
269.93M269.23M254.55M
Multiomics Revenue Growth
0.26%5.77%2.52%
Revenue (Other)
642.00K--
Revenue (Total)
594.95M593.82M573.45M
Revenue (Total) Growth
0.19%3.55%3.98%

Revenue Breakdown 3

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Multiomics Revenue
269.93M269.23M254.55M
Multiomics Revenue Growth
0.26%5.77%2.52%
Core Products Revenue
-197.63M196.50M
Core Products Revenue Growth
-0.57%2.31%
Sample Repository Solutions Revenue
-126.96M122.39M
Sample Repository Solutions Revenue Growth
-3.73%10.14%
Revenue (Total)
594.95M593.82M573.45M
Revenue (Total) Growth
0.19%3.55%3.98%

Adjusted EBIT

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Sample Management Solutions Adjusted Operating Income
29.55M27.55M11.11M
Sample Management Solutions Adjusted Operating Income Growth
7.27%148.06%-
Multiomics Adjusted Operating Income
-13.75M-11.94M-7.73M
Operating Income (Total)
-22.73M-26.84M-51.28M

Key Performance Indicators

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Organic Revenue Growth
3.00%-2.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai.